Opinion
15hOpinion
Despite threats, abuse, the death of a friend’s mother and widespread racist attacks, Leo Miyagee open armed and willing to cut some slack
The hip-hop, neo-soul singer songwriter contemplating shelving planned new single and video in the wake of abuse following TV documentary ...
Barron Trump said he placed a late night FaceTime call to the victim, a woman he met on social media, and was startled when ...
The group, made up of Liam Og O hAnnaidh, Naoise O Caireallain and JJ O Dochartaigh, will release a second studio album, titled Fenian, on April 24.
Rapper DigDat jailed for life after drive-by shooting in west London - DigDat, whose real name is Nathan Tokosi, was ...
Explore London with our City Sightseeing Hop-on Hop-off bus tour with over 25 carefully selected tour stops across 2 routes, you will be able to see all the key attractions London has to offer from ...
The UK government is appealing the September 2025 decision to dismiss the case brought against Liam Óg Ó hAnnaidh.
John Forté, an influential collaborator behind the Fugees, has died at 50, leaving behind a legacy tied to one of hip-hop’s most defining groups. Wyclef Jean reflected on John Forté’s lasting impact ...
In a music landscape always hungry for authentic voices, Lady London stands out not only for her lyrical skill but for the intellect and depth she brings to every platform she touches. Born Zaire ...
Hip-hop theatre pioneer Rickerby Hinds’ multi-award-winning Dreamscape comes to London following an acclaimed Edinburgh Festival Fringe run in 2025 and fresh from its Off-Broadway premiere, presented ...
"People are particularly excited when they hear something new, and Jim really brings that," says Radio 1's Jack Saunders In a very short time, Jim Legxacy has risen "from poverty to pop star". That's ...
U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated initiation of Phase 3 program expected in the second ...
U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated initiation of Phase 3 program expected in the second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results